Clostridium difficile

As one of its major molecular diagnostics-related revenue sources begins to slow down, Qiagen today outlined its plan to replace it with several new MDx initiatives and other molecular biology-related growth drivers.

Scientists from UK-based molecular diagnostics developer Lumora have published a pilot study demonstrating how a new heat elution-based sample prep method can be combined with isothermal amplification and Lumora's bioluminescent assay in real-time (BART) readout technology to qui

PrimeraDx said this week that the US Food and Drug Administration has granted 510(k) clearance for its ICEPlex C. difficile assay kit and ICEPlex molecular diagnostics system.

A study by researchers from the University of Oxford, has used whole genome sequencing to show that fidaxomicin is superior to vancomycin in preventing both relapse of a single strain of Clostridium difficile and reinfection with a new strain.

Researchers last week provided a glimpse of the clinical performance of a trio of extraction-free molecular assays currently being developed by clinical diagnostics firm Quidel.

Genomics tools provider Lucigen has developed an isothermal amplification polymerase ideally suited for use in loop-mediated isothermal amplification-based assays.

IntelligentMDx said today that it has received US Food and Drug Administration clearance for its IMDx C.